Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Other aortic diseases

The other aortic diseases include conditions that alter the inner surface, luminal contents or traumatic integrity of the aorta and require assessment distinct from the major categories of aneurysms, spontaneous acute aortic syndromes and aortitis. This term identifies a clinical grouping, not a single disease. Atheroma, mural thrombus and traumatic injury share the potential to cause serious events, but differ in mechanism, presentation and treatment: similarities between some imaging findings do not make therapeutic decisions interchangeable.

An initial distinction concerns the anatomical target. Atheroma develops in the intima and reflects the atherosclerotic process; a thrombus is a mass of blood adherent to the wall and may also appear in an aorta with few abnormalities; trauma mechanically damages one or more layers of the vessel. Consequences may occur far from the original site, such as stroke or limb ischemia, or directly in the wall as pseudoaneurysm and hemorrhage. This relationship between a local lesion and distant damage guides the entire diagnostic process.

Main clinical presentations

An aortic atheroma is common in people with cardiovascular risk factors and may be an incidental finding or a potential source of embolization. Its significance depends on location, thickness, ulceration and mobile components, as well as the clinical context. A small, stable plaque does not have the same implications as a large, irregular arch lesion in a patient with embolic events. Aortic atherosclerosis also indicates an overall vascular disease burden that warrants assessment even when no link to the presenting symptom has been established.

An aortic mural thrombus may be associated with an aneurysm or substantial atherosclerosis, or may occur as a primary form in a nonaneurysmal aorta that is normal or only mildly atherosclerotic. This distinction is crucial: a laminated thrombus within a known aneurysm is not equivalent to a mobile, pedunculated mass that has caused systemic embolization. Mobility, location and embolic history contribute more to risk than size alone. Identifying a primary form may also require targeted investigation for prothrombotic conditions, without automatically ordering indiscriminate laboratory panels for everyone.

A traumatic aortic injury results from external damage, often in the context of multiple trauma, or from a penetrating or iatrogenic mechanism. In blunt trauma, deceleration and deforming forces may cause intimal injury, hematoma, pseudoaneurysm or rupture. The priority is to consider aortic risk alongside hemorrhage, brain injury and other concomitant injuries. Management ranges from selective surveillance of minimal injuries to urgent repair and cannot be decided merely because the word trauma appears in a report.

Etiology and predisposing factors

The atherosclerotic process involves exposure to atherogenic lipoproteins, smoking, hypertension, diabetes and other risk determinants. Age and cardiovascular history influence the likelihood of finding aortic plaques but do not, by themselves, establish plaque instability. Distribution may be uneven, particularly involving the arch and the descending or abdominal aorta. A focal finding should therefore be interpreted in the context of the arterial system, distinguishing risk-factor control from the need to treat a particular embolic complication.

For thrombosis, endothelial injury, local flow abnormalities and hypercoagulable states are relevant. Aneurysms and wall irregularities favor secondary deposits, whereas malignancy, antiphospholipid antibody syndrome or hematological disorders may emerge in primary forms. In many cases, no single cause is identified. Etiological investigation must be proportionate to age, clinical presentation and baseline findings, because temporal association with a factor does not automatically establish causation, and some tests are altered by the acute phase or anticoagulants.

In traumatic injury, the main determinant is energy transfer to the wall, modulated by geometry, relatively fixed points and patient characteristics. The reported mechanism helps maintain suspicion even when physical examination is not particularly suggestive. Injury caused by a catheter or other procedure requires a different interpretation from road traffic trauma, although findings may be similar. A remote event may also explain a pseudoaneurysm discovered late, but does not justify considering an as-yet uncharacterized lesion benign.

Pathogenesis and pathophysiological consequences

The aortic surface may become a source of embolic material. With plaques, thrombotic components or atheromatous debris can detach; with mural thrombus, a blood clot of varying mobility can fragment. The size and composition of emboli influence the affected territories: a large embolus may occlude a peripheral artery, whereas cholesterol crystals may spread through the microcirculation. Distinguishing these mechanisms helps explain why ischemia with preserved palpable pulses does not rule out an aortic source.

The integrity of the wall, by contrast, is the central concern in trauma. Injury confined to the intima may remain stable or regress, whereas a contained rupture carries a different risk and requires specific assessment. Apparently preserved continuity of the outer contour does not always describe the full injury, and the context of multiple trauma can conceal symptoms and signs. Blood pressure, heart rate and organ perfusion must be balanced against the other injuries, avoiding automatic hemodynamic targets incompatible with the overall clinical picture.

The anatomical location partly determines the consequences. A proximal lesion may affect coronary and cerebral circulation; a source in the descending aorta may affect the kidneys, intestines and limbs. However, the association is not always straightforward: complex flows and concurrent disease require investigation of alternative sources. Merely finding a plaque in a patient with stroke does not prove that it caused the event, and an aortic thrombus does not exclude a simultaneous cardiac source.

A patent lumen does not guarantee the absence of danger. The aorta may maintain adequate blood flow while a mass adhering to its surface produces emboli, or while a contained traumatic injury threatens to rupture. Conversely, a substantial mural deposit may be stable and have accompanied a known condition for years. Assessment must therefore go beyond asking whether blood can flow: it concerns source stability, wall strength and the potential for injury in downstream territories.

Clinical manifestations and warning signs

Many lesions are identified during examinations performed for other reasons and remain asymptomatic. In this setting, the aim is to define morphology and risk without turning every wall irregularity into an emergency. The opposite applies when the finding accompanies an embolic event or recent trauma: its relationship to the acute presentation must be promptly investigated. Symptoms, timing and anatomy thus matter at least as much as the lesion's name and help avoid both underestimation and overtreatment.

The embolic manifestations include neurological deficits, sudden limb ischemia, abdominal pain from possible intestinal ischemia, renal infarction and digital lesions. Several territories may be affected, suggesting a proximal source. Urgency is determined by the threatened organ: aortic assessment must proceed alongside treatment of stroke or ischemia, rather than delaying it. Once the emergency has been addressed, identifying the source helps reduce the risk of further events and select suitable prevention.

Cholesterol microembolization may follow a more subacute course, with skin changes, worsening renal function and inflammatory signs, sometimes after a vascular procedure. It is not equivalent to acute thromboembolism and does not automatically create the same indication for anticoagulation. In trauma, chest or back pain and instability are important warning signs, but may be absent or attributed to other injuries. The likelihood of aortic injury must therefore be assessed by combining the accident mechanism, imaging findings and hemodynamic course.

History, examination and initial investigations

A targeted medical history addresses cardiovascular risk factors, previous embolic events, atrial fibrillation, malignancy, thrombosis, medications and recent procedures. In trauma, the circumstances, timing and associated injuries are essential. Examination covers pulses, limb perfusion, blood pressure, neurological findings and abdominal and skin assessment. These elements do not replace imaging; they determine its priority and scope, identify organ damage and help interpret an aortic finding when several explanations are possible.

Laboratory investigations are selected according to the clinical problem. Complete blood count, renal function, electrolytes and coagulation studies assist acute management and procedural preparation; lipid and glucose profiles inform cardiovascular prevention. Markers of injury and lactate may indicate ischemic consequences, but initially normal values do not exclude them in every vascular territory. Thrombophilia testing is targeted and is not routine for common aortic plaque, laminated aneurysmal thrombus or a clearly traumatic injury.

CT angiography allows rapid assessment of the wall, lumen, branches and surrounding structures. It is particularly useful in trauma and when searching for an embolic source along a large extent of the aorta. Transesophageal echocardiography dynamically characterizes many thoracic plaques and masses but has less accessible segments and requires consideration of contraindications. MRI can complement assessment in selected situations. Technique selection depends on the clinical question, urgency and patient risk, rather than on one hierarchy applicable to all conditions.

When presentation is embolic, cardiac evaluation looks for arrhythmias, intracardiac thrombi and valvular disease according to clinical probability. Identifying an aortic lesion may offer an additional explanation, but sometimes it coexists with an equally plausible cardiac source. In multiple trauma, CT is instead interpreted alongside assessment of other injuries and patient stability. These different pathways illustrate why the same aortic image may require different investigations: anatomical diagnosis becomes meaningful only when related to the original clinical question.

The quality of imaging is part of the diagnosis. Cardiac motion, incomplete contrast opacification and oblique planes can mimic or alter a finding, especially in the proximal aorta. A second technique is useful if it resolves important uncertainty, whereas simply repeating the study without correcting the technical limitation may add little. Follow-up examinations should use comparable measurements and reconstructions. This is essential both to establish thrombus disappearance and to recognize genuine progression of an initially small traumatic injury.

Interpretation of findings and differential diagnosis

Characterization must distinguish plaque, thrombus and wall injury, describing location, extent, surface, mobility where assessable, and relationship to the lumen. A filling defect is not automatically a primary thrombus: it may be related to an aneurysm, dissection, artifact or, rarely, another kind of mass. An atheromatous irregularity is not necessarily a penetrating ulcer, which entails a specific depth and mechanism of damage. Reporting precision directly affects the choice between prevention, anticoagulation and repair.

A penetrating aortic ulcer belongs to the spectrum of acute aortic syndromes or their chronic forms and requires dedicated wall assessment. Similarly, thrombus within the false lumen of a dissection should not be equated with a primary mural mass. Differential diagnosis also includes intramural hematoma and pseudoaneurysm of another origin. When imaging is inconclusive, multidisciplinary discussion and targeted use of a complementary modality are more helpful than a generic label that could lead to inappropriate treatment.

After identifying the lesion, causality and risk must be established. For an embolic event, other cardiac or arterial sources should be sought, and compatibility between the aortic location and affected territory verified. For trauma, severity and likelihood of progression are assessed alongside the condition of other organs. For an incidental finding, one should consider whether additional investigations could genuinely change management. This second step prevents an accurate morphological diagnosis from being followed by disproportionate or irrelevant clinical decisions.

Principles of treatment

In aortic atherosclerosis, treatment includes management of lipids, blood pressure, smoking, diabetes and overall cardiovascular risk. Antiplatelet use depends on the prevention setting and clinical characteristics; a mild incidental plaque is not automatically an indication for antithrombotic treatment. After events attributable to atheromatous disease, appropriate secondary prevention strategies are applied. Anticoagulation is not the universal response to complex plaque, as any reduction in embolic risk must be supported by evidence and balanced against bleeding.

For symptomatic primary aortic thrombus, anticoagulation is frequently used, but whether the source should be removed or excluded depends on mobility, site, persistence and recurrent embolic events. Treating the ischemic organ and treating the aortic source are related but distinct problems. In contrast, a secondary thrombus lining a stable aneurysm is not, in itself, an indication to initiate anticoagulants. The decision must specify which risk is to be reduced and how the response will be assessed, taking into account the limited quality of some of the literature on rare forms.

In aortic trauma, a minimal injury may be managed with observation and imaging based on specialist assessment, whereas more severe injuries require a repair strategy. Stent grafts play an important role in many injuries of the descending thoracic aorta with favorable anatomy, but this approach does not automatically apply to every site or age group. Intervention timing is coordinated with other urgent priorities in multiple trauma. Heparin use during a procedure must also be adapted to concomitant bleeding risk and technical requirements.

Aortic procedures themselves carry risks of embolization, ischemia, bleeding and device complications. Diffuse aortic atheroma or mobile thrombus must be recognized before manipulating guidewires and catheters because these findings may change access routes and strategy. Open surgery remains indicated in anatomical configurations or situations unsuitable for endovascular treatment. No repair eliminates the need for follow-up: the residual aorta and implanted material may develop problems different from those that prompted the original treatment.

In a patient with bleeding, antithrombotic drug selection must be coordinated with the cause of hemorrhage and the ischemic organ requiring protection. This issue is particularly apparent in multiple trauma but may also arise after a procedure or in a frail patient with embolism. The balance is reassessed over time: a temporary contraindication may subside, while a new complication may require a change. The therapeutic decision is therefore an ongoing process reviewed during the clinical course, not an automatic consequence of the lesion's name.

A successful repair may leave different care needs. Neurological deficits or loss of renal function may persist after embolization; after trauma, rehabilitation and extra-aortic injuries may predominate; after endovascular exclusion, the device must be monitored. Resolution of the initial problem must be described together with its sequelae, so that the absence of new imaging abnormalities does not lead to neglect of disability and functional recovery. Return to activity is also adapted to the overall condition, without imposing the same permanent restriction on every aortic disease.

Continuity between specialists helps coordinate decisions that might otherwise seem contradictory, such as anticoagulating a mobile thrombus while avoiding an antithrombotic drug not indicated for incidental plaque. Cardiologists, vascular surgeons, radiologists, neurologists and other professionals are involved according to the problem, sharing an understanding of the finding and its objectives. A clear plan documents the reason for treatment, its expected duration and the criteria for change. This improves follow-up and reduces the risk that an initial prescription is continued without reassessment.

New manifestations must be interpreted in light of the aortic history while keeping the differential diagnosis open. A patient with plaque may develop atrial fibrillation; someone whose thrombus has resolved may have pain from a different cause; and someone treated for trauma may experience a device complication. Clinical follow-up is not simply a search for recurrence of the same lesion. It includes recognizing new problems and updating risk while maintaining a precise relationship between anatomical evidence and treatment decisions.

Prognosis, surveillance and prevention of complications

The prognosis depends on the lesion and its consequences, not on membership in this general category. For atheroma, overall cardiovascular risk and any embolic history matter; for primary thrombus, recurrence, organ damage and the underlying cause are important; for trauma, the severity of the aortic injury and associated injuries are decisive. A mass that becomes smaller on imaging does not always indicate healing, as some material may have embolized. Comparing anatomical evolution with clinical status therefore remains essential to assess outcomes correctly.

The surveillance program should have an explicit objective: documenting plaque stability when useful, thrombus resolution or persistence, healing of traumatic injury, or repair integrity. Frequency and modality depend on risk and the likelihood that results will change treatment. Identical follow-up for all these conditions would lead to unnecessary testing in some patients and delays in others. Risk-factor management, continuity of treatment and prompt recognition of new symptoms complete prevention based on each disease's specific mechanism.

Bibliography
  1. Isselbacher EM et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022;80(24):e223–e393.
  2. Mazzolai L et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. European Heart Journal. 2024;45(36):3538–3700.
  3. Czerny M et al. EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ. European Journal of Cardio-Thoracic Surgery. 2024;65(2):ezad426.
  4. Wanhainen A et al. European Society for Vascular Surgery (ESVS) 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases – Editor's Choice. European Journal of Vascular and Endovascular Surgery. 2026;71(2):172–270.
  5. Gupta Y et al. CIRSE Standards of Practice on the Endovascular Management of Descending Thoracic Aortic Disease. Cardiovascular and Interventional Radiology. 2026;49:1645–1656.
  6. Evangelista A et al. Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. European Heart Journal – Cardiovascular Imaging. 2023;24(5):e65–e85.
  7. Aboyans V et al. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. European Heart Journal. 2021;42(39):4013–4024.
  8. Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–533.
  9. Ozkok A. Cholesterol-embolization syndrome: current perspectives. Vascular Health and Risk Management. 2019;15:209–220.
  10. Fayad ZY et al. Aortic mural thrombus in the normal or minimally atherosclerotic aorta. Annals of Vascular Surgery. 2013;27(3):282–290.
  11. Nguyen Q et al. Management Strategies for Descending Thoracic Aortic Thrombus: A Review of the Literature. Innovations. 2022;17(4):283–296.
  12. Arachchillage DJ et al. Thrombophilia testing: A British Society for Haematology guideline. British Journal of Haematology. 2022;198(3):443–458.
  13. Kleindorfer DO et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.